메뉴 건너뛰기




Volumn 23, Issue 3, 2000, Pages 289-295

Quantification of Tumor-Specific T Lymphocytes with the ELISPOT Assay

Author keywords

Cancer; ELISPOT assay; Peptide; T cells; Vaccine

Indexed keywords

CYTOKINE; HLA ANTIGEN CLASS 1; TUMOR ANTIGEN;

EID: 0034033763     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-200005000-00001     Document Type: Review
Times cited : (60)

References (50)
  • 1
    • 0029642252 scopus 로고
    • Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3.
    • Marchand M, Weynants P, Rankin E, et al. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 1995; 63:883-5.
    • Marchand M, Weynants P, Rankin E, et al. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer 1995; 63:883-5.
    • (1995) Int J Cancer , vol.63 , pp. 883
    • Marchand, M.1    Weynants, P.2    Rankin, E.3
  • 2
    • 0029997742 scopus 로고    scopus 로고
    • Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens.
    • Jäger E, Bernhard H, Romero P, et al. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int J Cancer 1996; 66:162-9.
    • Jäger E, Bernhard H, Romero P, et al. Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int J Cancer 1996; 66:162-9.
    • (1996) Int J Cancer , vol.66 , pp. 162
    • Jäger, E.1    Bernhard, H.2    Romero, P.3
  • 3
    • 0031941423 scopus 로고    scopus 로고
    • Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells.
    • Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med 1998; 4:328-32.
    • Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide-or tumor lysate-pulsed dendritic cells. Nature Med 1998; 4:328-32.
    • (1998) Nature Med , vol.4 , pp. 328
    • Nestle, F.O.1    Alijagic, S.2    Gilliet, M.3
  • 4
    • 0031890206 scopus 로고    scopus 로고
    • Immunologic and therapeutic evaluation of a synthetic peptide vaccine for treament of patients with metastatic melanoma.
    • Rosenberg SA, Yang JC, Schwartzentruber DJ, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for treament of patients with metastatic melanoma. Nature Med 1998; 4:321-7.
    • Rosenberg SA, Yang JC, Schwartzentruber DJ, et al. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for treament of patients with metastatic melanoma. Nature Med 1998; 4:321-7.
    • (1998) Nature Med , vol.4 , pp. 321
    • Rosenberg, S.A.1    Yang, J.C.2    Schwartzentruber, D.J.3
  • 5
    • 0031880570 scopus 로고    scopus 로고
    • Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy.
    • Romero P, Cerottini J-C, Waanders GA. Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy. Mol Med Today 1998; 4:305-12.
    • Romero P, Cerottini J-C, Waanders GA. Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy. Mol Med Today 1998; 4:305-12.
    • (1998) Mol Med Today , vol.4 , pp. 305
    • Romero, P.1    Cerottini, J.-C.2    Waanders, G.A.3
  • 6
    • 0031436611 scopus 로고    scopus 로고
    • Monitoring of cancer patients undergoing active or passive immunotherapy.
    • Salgaller ML. Monitoring of cancer patients undergoing active or passive immunotherapy. J Immunother 1997; 20:1-14.
    • Salgaller ML. Monitoring of cancer patients undergoing active or passive immunotherapy. J Immunother 1997; 20:1-14.
    • (1997) J Immunother , vol.20 , pp. 1
    • Salgaller, M.L.1
  • 7
    • 0025255387 scopus 로고
    • Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link.
    • Ullman KS, Northrop JP, Verweij CL, Crabtree GR. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu Rev Immunol 1990; 8:421-52.
    • (1990) Annu Rev Immunol , vol.8 , pp. 421
    • Ullman, K.S.1    Northrop, J.P.2    Verweij, C.L.3    Crabtree, G.R.4
  • 8
    • 0029874657 scopus 로고    scopus 로고
    • T cell antigen receptor signal transduction pathways.
    • Cantrell D. T cell antigen receptor signal transduction pathways. Annu Rev Immunol 1996; 14:259-74.
    • (1996) Annu Rev Immunol , vol.14 , pp. 259
    • Cantrell, D.1
  • 9
    • 0028932731 scopus 로고
    • The CTL's kiss of death.
    • Berke G. The CTL's kiss of death. Cell 1995; 81:9-12.
    • (1995) Cell , vol.81 , pp. 9
    • Berke, G.1
  • 10
    • 0031172162 scopus 로고    scopus 로고
    • Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition.
    • Valitutti S, Lanzavecchia A. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol Today 1997; 6:299-304.
    • (1997) Immunol Today , vol.6 , pp. 299
    • Valitutti, S.1    Lanzavecchia, A.2
  • 11
    • 0025286210 scopus 로고
    • Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation.
    • Harding CV, Unanue ER. Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation. Nature 1990; 346:574-6.
    • (1990) Nature , vol.346 , pp. 574
    • Harding, C.V.1    Unanue, E.R.2
  • 12
    • 0014251127 scopus 로고
    • Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogenic target cells in vitro; inhibition by isoantibodies and by drugs.
    • Brunner KT, Mauel J, Cerottini JC, Chapus B. Quantitative assay of the lytic action of immune lymphoid cells on 51Cr-labelled allogenic target cells in vitro; inhibition by isoantibodies and by drugs. Immunolology 1968; 14:181-96.
    • (1968) Immunolology , vol.14 , pp. 181
    • Brunner, K.T.1    Mauel, J.2    Cerottini, J.C.3    Chapus, B.4
  • 13
    • 0032055984 scopus 로고    scopus 로고
    • Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo.
    • Spaeny-Dekking EH, Hanna WL, Wolbink AM, et al. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J Immunol 1998; 160:3610-16.
    • (1998) J Immunol , vol.160 , pp. 3610
    • Spaeny-Dekking, E.H.1    Hanna, W.L.2    Wolbink, A.M.3
  • 14
    • 0020506697 scopus 로고
    • The relationship between immune interferon production and proliferation in antigen-specific MHC-restricted T cell lines and clones.
    • Hecht TT, Longo DL, Matis LA. The relationship between immune interferon production and proliferation in antigen-specific MHC-restricted T cell lines and clones. J Immunol 1983; 131:1049-55.
    • (1983) J Immunol , vol.131 , pp. 1049
    • Hecht, T.T.1    Longo, D.L.2    Matis, L.A.3
  • 15
    • 0030590638 scopus 로고    scopus 로고
    • A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides.
    • Mayer S, Scheibenbogen C, Lee KH, et al. A sensitive proliferation assay to determine the specific T cell response against HLA-A2.1-binding peptides. J Immunol Methods 1996; 197:131-7.
    • (1996) J Immunol Methods , vol.197 , pp. 131
    • Mayer, S.1    Scheibenbogen, C.2    Lee, K.H.3
  • 16
    • 0027459260 scopus 로고
    • Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens.
    • Hom SS, Schwarzentruber DJ, Rosenberg SA, Topalian SL. Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigens. J Immunother 1993; 13:18-30.
    • (1993) J Immunother , vol.13 , pp. 18
    • Hom, S.S.1    Schwarzentruber, D.J.2    Rosenberg, S.A.3    Topalian, S.L.4
  • 17
    • 0028136948 scopus 로고
    • Patterns of cytokine release of unselected and CD8-selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo.
    • Steger GG, Pierce WC, Figlin R, et al. Patterns of cytokine release of unselected and CD8-selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6 nonsecreting TIL in vitro and correlation with complete response in vivo. Clin Immunol Immunopathol 1994; 72:237-47.
    • (1994) Clin Immunol Immunopathol , vol.72 , pp. 237
    • Steger, G.G.1    Pierce, W.C.2    Figlin, R.3
  • 18
    • 0028047913 scopus 로고
    • Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells.
    • Tanguay S, Killion JJ. Direct comparison of ELISPOT and ELISA-based assays for detection of individual cytokine-secreting cells. Lymphokine and Cytokine Research 1994; 4:259-63.
    • (1994) Lymphokine Cytokine Research , vol.4 , pp. 259
    • Tanguay, S.1    Killion, J.J.2
  • 19
    • 0021020342 scopus 로고
    • A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells.
    • Czerkinsky CC, Nielsson LA, Nygren H, Ouchterlony O, Tarkowski A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J Immunol Methods 1983; 65:109-21.
    • (1983) J Immunol Methods , vol.65 , pp. 109
    • Czerkinsky, C.C.1    Nielsson, L.A.2    Nygren, H.3    Ouchterlony, O.4    Tarkowski, A.5
  • 20
    • 0023945701 scopus 로고
    • Reverse ELISPOT assay for clonal analysis of cytokine production. Enumeration of gamma-interferon secreting cells.
    • Czerkinsky CC, Andersson G, Ekre HP, et al. Reverse ELISPOT assay for clonal analysis of cytokine production. Enumeration of gamma-interferon secreting cells. J Immunol Methods 1988; 110:29-36.
    • (1988) J Immunol Methods , vol.110 , pp. 29
    • Czerkinsky, C.C.1    Andersson, G.2    Ekre, H.P.3
  • 21
    • 0027488482 scopus 로고
    • Number of interleulin-4-and interferon-gamma-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation.
    • elGhazali GE, Paulie S, Andersson G, et al. Number of interleulin-4-and interferon-gamma-secreting human T cells reactive with tetanus toxoid and the mycobacterial antigen PPD or phytohemagglutinin: distinct response profiles depending on the type of antigen used for activation. Eur J Immunol 1993; 23:2740-5.
    • (1993) Eur J Immunol , vol.23 , pp. 2740
    • elGhazali, G.E.1    Paulie, S.2    Andersson, G.3
  • 22
    • 0027461902 scopus 로고
    • Detection of single cells secreting IFN-gamma, IL-6, and IL-10 in irreversible rejected human kidney allografts, and their modulation by IL-2 and IL-4.
    • Merville P, Pouteil-Noble C, Wijdenes J, Potaux L, Touraine JL, Banchereau J. Detection of single cells secreting IFN-gamma, IL-6, and IL-10 in irreversible rejected human kidney allografts, and their modulation by IL-2 and IL-4. Transplantation 1993; 55:639-46.
    • (1993) Transplantation , vol.55 , pp. 639
    • Merville, P.1    Pouteil-Noble, C.2    Wijdenes, J.3    Potaux, L.4    Touraine, J.L.5    Banchereau, J.6
  • 23
    • 0026719744 scopus 로고
    • Reverse ELISPOT assay for clonal analysis of cytokine production. II. Enumeration of interleukin-1-secreting cells amplified (avidin-biotin anti-peroxidase) assay.
    • Nordstrom I, Ferrua B. Reverse ELISPOT assay for clonal analysis of cytokine production. II. Enumeration of interleukin-1-secreting cells amplified (avidin-biotin anti-peroxidase) assay. J Immunol Methods 1992; 150:199-206.
    • (1992) J Immunol Methods , vol.150 , pp. 199
    • Nordstrom, I.1    Ferrua, B.2
  • 24
    • 0029953952 scopus 로고    scopus 로고
    • Detection and quantification of blood-derived CD8-T lymphocytes secreting TNFa in response to HLA-A2.1-binding melanoma and viral peptide antigens.
    • Herr W, Schneider J, Lohse AW, et al. Detection and quantification of blood-derived CD8-T lymphocytes secreting TNFa in response to HLA-A2.1-binding melanoma and viral peptide antigens. J Immunol Methods 1996; 191:131-43.
    • (1996) J Immunol Methods , vol.191 , pp. 131
    • Herr, W.1    Schneider, J.2    Lohse, A.W.3
  • 25
    • 0030794379 scopus 로고    scopus 로고
    • Characterization of T cell response to herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) using a TNF-beta ELISPOT cytokine assay.
    • Schmid DS, Thieme ML, Gary Jr, HE Reeves WC. Characterization of T cell response to herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) using a TNF-beta ELISPOT cytokine assay. Arch Virol 1997; 142:1659-71.
    • (1997) Arch Virol , vol.142 , pp. 1659
    • Schmid, D.S.1    Thieme, M.L.2    Gary, H.E.3    Reeves, W.C.4
  • 26
    • 0031825621 scopus 로고    scopus 로고
    • Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment.
    • Medhat A, Shehata M, Bucci K, et al. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigens correlates with lack of reinfection after treatment. J Infect Dis 1998; 178:512-19.
    • (1998) J Infect Dis , vol.178 , pp. 512
    • Medhat, A.1    Shehata, M.2    Bucci, K.3
  • 28
    • 0031590669 scopus 로고    scopus 로고
    • Evaluation of the interferon-γ ELISPOT-assay for quantification of peptide-specific T lymphocytes from peripheral blood.
    • Schmittel A, Keilholz U, Scheibenbogen C. Evaluation of the interferon-γ ELISPOT-assay for quantification of peptide-specific T lymphocytes from peripheral blood. J Immunol Methods 1997; 210:167-74.
    • (1997) J Immunol Methods , vol.210 , pp. 167
    • Schmittel, A.1    Keilholz, U.2    Scheibenbogen, C.3
  • 29
    • 0031009421 scopus 로고    scopus 로고
    • Computer-assisted, quantitative cytokine enzyme-linked immunospot analysis of human immune effector cell function.
    • Cui Y, Chang LJ. Computer-assisted, quantitative cytokine enzyme-linked immunospot analysis of human immune effector cell function. Biotechniques 1997; 22:1146-9.
    • (1997) Biotechniques , vol.22 , pp. 1146
    • Cui, Y.1    Chang, L.J.2
  • 30
    • 0030934741 scopus 로고    scopus 로고
    • The use of computer-assisted video image analysis for the quantification of CD8+ T lymphocytes producing tumor necrosis factor a spots in response to peptide antigens.
    • + T lymphocytes producing tumor necrosis factor a spots in response to peptide antigens. J Immunol Methods 1997; 203:141-52.
    • (1997) J Immunol Methods , vol.203 , pp. 141
    • Herr, W.1    Linn, B.2    Leister, N.3
  • 32
    • 0030916776 scopus 로고    scopus 로고
    • Analysis of the T cell response to tumor and viral peptide antigens by an IFN-γ-ELISPOT assay.
    • Scheibenbogen C, Lee K-H, Stevanovic S, et al. Analysis of the T cell response to tumor and viral peptide antigens by an IFN-γ-ELISPOT assay. Int J Cancer 1997; 71:932-6.
    • (1997) Int J Cancer , vol.71 , pp. 932
    • Scheibenbogen, C.1    Lee, K.-H.2    Stevanovic, S.3
  • 33
    • 85026176090 scopus 로고    scopus 로고
    • Scheibenbogen C, Schmittel A, Keilholz U, et al. Phase II trial of vaccination with tyrosinase peptides and GM-CSF in melanoma. J Immunother. in press, 2000.
    • Scheibenbogen C, Schmittel A, Keilholz U, et al. Phase II trial of vaccination with tyrosinase peptides and GM-CSF in melanoma. J Immunother. in press, 2000.
  • 34
    • 85026172539 scopus 로고    scopus 로고
    • Lewis JJ, Janetzki S, Wang S, et al. Phase I trial of vaccination with tyrosinase peptide plus QS-21 in melanoma (Abstract 1650). J Clin Oncol 1998;17.
    • Lewis JJ, Janetzki S, Wang S, et al. Phase I trial of vaccination with tyrosinase peptide plus QS-21 in melanoma (Abstract 1650). J Clin Oncol 1998;17.
  • 36
    • 0031027541 scopus 로고    scopus 로고
    • A sensitive ELISPOT assay for detection of CD8-T-lymphocytes specific for HLA class I binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients.
    • Scheibenbogen C, Lee K-H, Mayer S, et al. A sensitive ELISPOT assay for detection of CD8-T-lymphocytes specific for HLA class I binding peptide epitopes derived from influenza proteins in the blood of healthy donors and melanoma patients. Clin Cancer Res 1997; 3:221-6.
    • (1997) Clin Cancer Res , vol.3 , pp. 221
    • Scheibenbogen, C.1    Lee, K.-H.2    Mayer, S.3
  • 37
    • 0033524348 scopus 로고    scopus 로고
    • Induction of tyrosinase-reactive T cells by the treatment with dacarbacin, cisplatin, interferon-alpha—interleukin-2 in patients with metastatic melanoma.
    • Schmittel A, Keilholz U, Max R, Thiel E, Scheibenbogen C. Induction of tyrosinase-reactive T cells by the treatment with dacarbacin, cisplatin, interferon-alpha—interleukin-2 in patients with metastatic melanoma. Int J Cancer 1999; 80:39-43.
    • (1999) Int J Cancer , vol.80 , pp. 39
    • Schmittel, A.1    Keilholz, U.2    Max, R.3    Thiel, E.4    Scheibenbogen, C.5
  • 38
    • 0032054736 scopus 로고    scopus 로고
    • Human melanoma-specific, noncytolytic CD8+ T cells that can synthesize type I cytokine.
    • + T cells that can synthesize type I cytokine. Cancer Res 1998; 58:1363-6.
    • (1998) Cancer Res , vol.58 , pp. 1363
    • Chakraborty, N.G.1    Mukherji, B.2
  • 39
    • 0029984048 scopus 로고    scopus 로고
    • Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide.
    • Brossart P, Bevan MJ. Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide. J Exp Med 1996; 183:2449-58.
    • (1996) J Exp Med , vol.183 , pp. 2449
    • Brossart, P.1    Bevan, M.J.2
  • 40
    • 0030765987 scopus 로고    scopus 로고
    • Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine.
    • + T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine. Int J Cancer 1997; 72:972-6.
    • (1997) Int J Cancer , vol.72 , pp. 972
    • Reynolds, S.R.1    Oratz, R.2    Shapiro, R.L.3
  • 41
    • 0342378189 scopus 로고    scopus 로고
    • A comparison between ELISPOT methods for the detection of cytokine producing cells: greater sensitivity and specificity using ELISA plates as compared to nitrocellulose membranes.
    • Rönnelid J, Klareskog L. A comparison between ELISPOT methods for the detection of cytokine producing cells: greater sensitivity and specificity using ELISA plates as compared to nitrocellulose membranes. J Immunol Methods 1997; 200:17-26.
    • (1997) J Immunol Methods , vol.200 , pp. 17
    • Rönnelid, J.1    Klareskog, L.2
  • 42
    • 85026166544 scopus 로고    scopus 로고
    • Weber JS, Spears L, Jeffery G, et al. A phase I trial of a MART-1 HLA-A2 restricted peptide vaccine for resected high risk melanoma (Abstract 1676). J Clin Oncol 1998;17.
    • Weber JS, Spears L, Jeffery G, et al. A phase I trial of a MART-1 HLA-A2 restricted peptide vaccine for resected high risk melanoma (Abstract 1676). J Clin Oncol 1998;17.
  • 43
    • 0031716189 scopus 로고    scopus 로고
    • Immunization of patients with melanoma peptides vaccines: immunologic assessment using the ELISPOT assay.
    • Pass HA, Schwarz SL, Wunderlich JR, Rosenberg SA. Immunization of patients with melanoma peptides vaccines: immunologic assessment using the ELISPOT assay. Cancer J Sci Am 1998; 4:316-23.
    • (1998) Cancer J Sci Am , vol.4 , pp. 316
    • Pass, H.A.1    Schwarz, S.L.2    Wunderlich, J.R.3    Rosenberg, S.A.4
  • 44
    • 85026171255 scopus 로고    scopus 로고
    • Mammi C, Herr W, Del Bello D, et al. Analysis by ELISPOT assay of CTL precursors specific for HLA-A2.1-binding ErbB-2 peptides in breast cancer patients (Abstract 62). Proc Am Assoc Cancer Res 1998;39.
    • Mammi C, Herr W, Del Bello D, et al. Analysis by ELISPOT assay of CTL precursors specific for HLA-A2.1-binding ErbB-2 peptides in breast cancer patients (Abstract 62). Proc Am Assoc Cancer Res 1998;39.
  • 45
    • 85026167403 scopus 로고    scopus 로고
    • Salgaller ML, Lodge PA, Tjoa BA, et al. Monitoring of prostate-specific membrane antigen (PSMA)-specific immune responses and prostate markers in a phase II clinical trial with patients infused with dendritic cells pulsed with PSMA-derived peptides (Abstract 1187). Proc Am Assoc Cancer Res 1998;39.
    • Salgaller ML, Lodge PA, Tjoa BA, et al. Monitoring of prostate-specific membrane antigen (PSMA)-specific immune responses and prostate markers in a phase II clinical trial with patients infused with dendritic cells pulsed with PSMA-derived peptides (Abstract 1187). Proc Am Assoc Cancer Res 1998;39.
  • 46
    • 85026159547 scopus 로고    scopus 로고
    • Valone FH, Small EJ, Whisenant S, et al. Immunotherapy of hormone refractory prostate cancer with antigen-pulsed dendritic cells: a phase I/II trial (Abstract 1334). J Clin Oncol 1998;17.
    • Valone FH, Small EJ, Whisenant S, et al. Immunotherapy of hormone refractory prostate cancer with antigen-pulsed dendritic cells: a phase I/II trial (Abstract 1334). J Clin Oncol 1998;17.
  • 47
    • 0029983701 scopus 로고    scopus 로고
    • Modulation of anti-idiotypic immune response by immunization with autologous M-component protein in multiple myeloma patients.
    • Bergenbrant S, Yi Q, österborg A, et al. Modulation of anti-idiotypic immune response by immunization with autologous M-component protein in multiple myeloma patients. Br J Haematol 1996; 92:840-6.
    • (1996) Br J Haematol , vol.92 , pp. 840
    • Bergenbrant, S.1    Yi, Q.2    österborg, A.3
  • 48
    • 0032055911 scopus 로고    scopus 로고
    • Idiotype immunization combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8+ and CD4-specific T-cell responses.
    • + and CD4-specific T-cell responses. Blood 1998; 91:2459-66.
    • (1998) Blood , vol.91 , pp. 2459
    • österborg, A.1    Yi, Q.2    Henriksson, L.3
  • 49
    • 15144345621 scopus 로고    scopus 로고
    • Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice.
    • Hanke T, Blanchard TJ, Schneider J, et al. Immunogenicities of intravenous and intramuscular administrations of modified vaccinia virus Ankara-based multi-CTL epitope vaccine for human immunodeficiency virus type 1 in mice. J Gen Virol 1998; 70:83-90.
    • (1998) J Gen Virol , vol.70 , pp. 83
    • Hanke, T.1    Blanchard, T.J.2    Schneider, J.3
  • 50
    • 0030932988 scopus 로고    scopus 로고
    • Induction of mucosal immunity against herpes simplex viris by plasmid DNA immunization.
    • Kukulin N, Daheshia M, Karem K, Manickan E, Rouse BT. Induction of mucosal immunity against herpes simplex viris by plasmid DNA immunization. J Virol 1997; 74:3138-45.
    • (1997) J Virol , vol.74 , pp. 3138
    • Kukulin, N.1    Daheshia, M.2    Karem, K.3    Manickan, E.4    Rouse, B.T.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.